Strategic Wealth Partners, Ltd. Charles River Laboratories International, Inc. Transaction History
Strategic Wealth Partners, Ltd.
- $1.14 Billion
- Q2 2025
A detailed history of Strategic Wealth Partners, Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Strategic Wealth Partners, Ltd. holds 32 shares of CRL stock, worth $5,691. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32Holding current value
$5,691% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
640Shares Held
52.9MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$1.03 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$905 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$670 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$387 Million0.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$331 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.05B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...